 |
L-threonine |
|---|---|
| Trade Name | |
| Orphan Indication | Spasticity associated with familial spastic paraparesis |
| USA Market Approval | USA |
| USA Designation Date | 1992-07-24 00:00:00 |
| Sponsor | Interneuron Pharmaceuticals, Inc.;99 Hayden Ave., Suite 200;Lexington, Massachusetts, 02421 |
